2023
Unindicated Cervical Cancer Screening in Adolescent Females Within a Large Healthcare System in the United States
Hosier H, Sheth S, Oliveira C, Perley L, Vash-Margita A. Unindicated Cervical Cancer Screening in Adolescent Females Within a Large Healthcare System in the United States. Obstetrical & Gynecological Survey 2023, 78: 470-472. DOI: 10.1097/ogx.0000000000001179.Commentaries, Editorials and LettersCervical cancer screeningIncidence rateUnindicated testsPatient-specific variablesCervical cancerCancer screeningHPV testingYale New Haven Health SystemCervical cancer screening testsAdolescent femalesEligible young womenRepeated cross-sectional studyWell-woman examinationsAtypical squamous cellsHealth system patientsCancer screening testsWomen ages 21Cross-sectional studyLow incidence rateLarge healthcare systemElectronic medical recordsEvidence-based strategiesSelf-reported raceGuideline adherenceHPV test
2020
The association between anti-Müllerian hormone and vitamin 25(OH)D serum levels and polycystic ovarian syndrome in adolescent females
Simpson S, Seifer DB, Shabanova V, Lynn AY, Howe C, Rowe E, Caprio S, Vash-Margita A. The association between anti-Müllerian hormone and vitamin 25(OH)D serum levels and polycystic ovarian syndrome in adolescent females. Reproductive Biology And Endocrinology 2020, 18: 118. PMID: 33218348, PMCID: PMC7679991, DOI: 10.1186/s12958-020-00676-y.Peer-Reviewed Original ResearchConceptsPolycystic ovarian syndromeRotterdam diagnostic criteriaNon-PCOS groupMedian AMHOvarian syndromePCOS groupDiagnostic criteriaAnti-Müllerian hormone levelsAdolescent femalesRetrospective chart reviewTraditional clinical markersAnti-Müllerian hormoneCross-sectional studyWilcoxon rank sum testSignificant unadjusted differencesRank sum testD deficiencyChart reviewClinical featuresEndocrinology clinicSerum levelsAdjusted analysisUnadjusted comparisonsInsurance typeSurrogate marker